Severe COVID-19 in Vaccinated Adults With Hematologic Cancers in the Veterans Health Administration.

ABSTRACT:

Importance

With SARS-CoV-2 transforming into an endemic disease and with antiviral treatments available, it is important to establish which patients remain at risk of severe COVID-19 despite vaccination.

Objective

To quantify the associations of clinical and demographic variables with odds of severe COVID-19 among patients with hematologic cancers.

Design, setting, and participants

This case-control study included all patients with hematologic malignant neoplasms in the national Veterans Health Administration (VHA) who had documented SARS-CoV-2 infection after vaccination. Groups of patients with severe (cases) vs nonsevere (controls) COVID-19 were compared. Data were collected between January 1, 2020, and April 5, 2023, with data on infection collected between Januar

SUBMITTER: Anand ST 

PROVIDER: S-EPMC10891464 | biostudies-literature | 2024 Feb

REPOSITORIES: biostudies-literature